Neorecormon (epoetin beta): Reviews and patient testimonials
Back to the list of medications
Medication indications
Neorecormon Solution for Injection in Pre-Filled Syringe
NeoRecormon is indicated for:
- Treatment of symptomatic anaemia associated with chronic renal failure in adult and paediatric patients.
- Prevention of anaemia of prematurity in infants with a birth weight of 750 to 1500 g and a gestational age of less than 34 weeks.
- Treatment of symptomatic anaemia in adult patients with non-myeloid malignancies receiving chemotherapy.
- Increasing the yield of autologous blood from patients in a pre-donation programme.
Its use in this indication must be balanced against the reported increased risk of thromboembolic events. Treatment should only be given to patients with moderate anaemia (Hb 10 - 13 g/dl [6.21 - 8.07 mmol/l], no iron deficiency) if blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). See section 5.1
Route of administration: Injectable
Molecule: epoetin beta
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.